BioSpace News Archive

Enzychem Lifesciences (KOSDAQ: 183490), a late-stage biotechnology company, announced today that the company has completed the final Clinical Study Report (CSR) for their Phase 2 study of EC-18 in Chemoradiation-induced Oral Mucositis (CRIOM)/.

BriOri BioTech, an emerging pre-clinical stage biotech company focused on developing a pipeline of opiate-free topical pain medications, announces its patent for “Topical Compositions Containing Rofecoxib (Vioxx) and Methods of Making and Using the Same” was issued on March 1, 2022.

Romark announced today that results of its Vanguard Co-V clinical trial of NT-300 (nitazoxanide extended-release tablets, 300 mg) for treatment of mild or moderate COVID-19 have been published in Lancet’s eClinicalMedicine.

ONWARD Medical N.V., the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, announces the start of enrollment in the LIFT Home Study.

Immune-Onc Therapeutics, Inc. (“Immune-Onc”),today announced that two abstracts on IO-108, a novel myeloid checkpoint inhibitor targeting Leukocyte Immunoglobulin-Like Receptor B2 (LILRB2, also known as ILT4), were accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting.

Nuvectis Pharma, Inc. announced that Ron Bentsur, Chairman and Chief Executive Officer, will participate in a fireside chat at the 34th Annual Roth Conference.

Rapidly growing geriatric population worldwide and rising prevalence of cancer, orthopedic, neurodegenerative, and other age-related illnesses are among the key factors driving the global Regenerative Medicine market revenue growth.

The industry analysis report is considered a valuable source of information about the global Migraine Nasal Spray industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

Tevard Biosciences, the pioneer of tRNA-based treatments for severe genetic diseases, today announced the appointment of Paul Schimmel, Ph.D., Susan Ackerman, Ph.D., and Nicholas Ingolia, Ph.D., to its scientific advisory board.

Southern Spine, LLC, an ISO 13485:2016 certified manufacturer of implants and instruments for spinal surgery based in Macon, Georgia, announces that it has formed its first Center of Excellence together with Integrated Pain Associates in Killeen, Texas.